Metacognitive training for schizophrenia: A multicentre randomised controlled trial

Schizophrenia Research

Volumn 157, Issue 1-3, 2014, Pages 99-106

  Briki, Malick ^a,b   Monnin, Julie ^c   Haffen, Emmanuel ^b,c   Sechter, Daniel ^b,c   Favrod, JérÔme ^d,e   Netillard, Christian ^f   Cheraitia, Elisabeth ^f   Marin, Karine ^g   Govyadovskaya, Svetlana ^h   Tio, Grégory ^c   Bonin, Bernard ^a   Chauvet Gelinier, Jean Christophe ^a   Leclerc, Stéphanie ^a   Hodé, Yann ⁱ   Vidailhet, Pierre ^j   Berna, Fabrice ^j   Bertschy, Anna Zinetti ^j   Vandel, Pierre ^b,c  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b University Hospital of Besançon   (France)

^c UNIVERSITY HOSPITAL OF BESANÇON   (France)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY OF APPLIED SCIENCES WESTERN SWITZERLAND   (Switzerland)

^f Clinical Psychiatry Department Hospital of Novillars   (France)

^g Clinical Psychiatry Department Hospital of Saint Ylie   (France)

^h Clinical Psychiatry Department Hospital of Bavilliers   (France)

ⁱ Hospital Hygiene Service   (France)

^j UNIVERSITY HOSPITAL OF STRASBOURG   (France)

more..

Author keywords

Cognitive biases; Insight; Metacognitive training; Randomised study; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CALGARY DEPRESSION SCALE; CONTROLLED STUDY; DELUSION; FEMALE; GROUP THERAPY; HALLUCINATION; HUMAN; INTROSPECTION; MAJOR CLINICAL STUDY; MALE; METACOGNITIVE TRAINING; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PRETEST POSTTEST DESIGN; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOTHERAPY; PSYCHOTIC SYMPTOM RATING SCALE; QUALITY OF LIFE; QUALITY OF LIFE SCALE; RANDOMIZED CONTROLLED TRIAL; SCALE TO ASSESS UNAWARENESS OF MENTAL DISORDER; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUPPORTIVE THERAPY; SYMPTOM; THERAPY EFFECT; TREATMENT DURATION; CLINICAL TRIAL; COGNITIVE THERAPY; DELUSIONS; FRANCE; HALLUCINATIONS; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; PSYCHOTIC DISORDERS; SOCIAL ADAPTATION; THINKING; TIME; TREATMENT OUTCOME;

ADULT; COGNITIVE THERAPY; DELUSIONS; FEMALE; FRANCE; HALLUCINATIONS; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; THINKING; TIME FACTORS; TREATMENT OUTCOME;

EID: 84904126835     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.06.005     Document Type: Article

References (44)

1. Addington D., Addington J.A. Depression rating scale for schizophrenia. Schizophr. Res. 1990, 3:247-251.
2. Aghotor J., Pfueller U., Moritz S., Weisbrod M., Roesch-Ely D. Metacognitive training for patients with schizophrenia: feasibility and preliminary evidence for its efficacy. J. Behav. Ther. Exp. Psychiatry 2010, 41:207-211.
3. Amador X.F., Flaum M., Andreasen N.C., et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch. Gen. Psychiatr. 1994, 51:826-836.
4. Beck A.T., Baruch E., Batler J.M., Steer R.A., Warma D.M. A new instrument for measuring insight: the Beck Cognitive Insight Scale. Schizophr. Res. 2004, 68:319-324.
5. Briki M., Haffen E., Sechter D., Vandel P. Metacognitive training for schizophrenia: a french pilot study. J. Neuropsychiatry Clin. Neurosci. 2014, 26(2):E32-E33.
6. David A.S., Bedford N., Wiffen B., et al. Failures of metacognition and lack of insight in neuropsychiatric disorders. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2012, 367(1594):1379-1390. (19).
7. Favrod J., Maire A., Bardy-Linder S., Pernier S., Bonsack C. Improving insight into delusions: a pilot study of metacognitive training. J. Adv. Nurs. 2011, 67(2):401-407.
8. Favrod J., Rexhaj S., Ferrari P., Bardy S., Hayoz C., Morandi S., et al. French version validation of the psychotic symptom rating scales (PSYRATS) for outpatients with persistent psychotic symptoms. BMC Psychiatr. 2012, 12:161. 10.1186/1471-244X-12-161.
9. Favrod J., Rexhaj S., Bardy S., Ferrari P., Hayoz C., Moritz S., Conus P., Bonsack C. Sustained antipsychotic effect of metacognitive training in psychosis: A randomized-controlled study. Eur. Psychiatry. 2014, 29(5):275-281.
10. Fenton W.S., Blyler C.R., Heinssen R.K. Determinants of medication compliance in schizophrenia: empirical and clinical. Schizophr. Bull. 1997, 23:637-651. (Review).
11. Haddock G., McCarron J., Tarrier N., Faragher E.B. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol. Med. 1999, 29(4):879-889.
12. Heinrichs D.W., Hanlon T.E., Carpenter W.T. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr. Bull. 1984, 10(3):388-398.
13. Hollon S.D., Wampold B.E. Are randomized controlled trials relevant to clinical practice?. Can. J. Psychiatr. 2009, 54:637-639.
14. Kay S.R., Opler L.A., Fiszbein A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
15. Kircher T.T.J., Koch K., Stottmeister F., Durst V. Metacognition and reflexivity in patients with schizophrenia. Psychopathology 2007, 40:254-260.
16. Kumar D., Ul Haq M.Z., Dubey I., Dotivala K.N., Siddiqui S.V., Prakash R., Abhishek P., Nizamie S.H. Effect of meta-cognitive training in the reduction of positive symptoms in schizophrenia. Eur. J. Psychother. Couns. 2010, 12(2):149-158.
17. Lançon C., Auquier P., Llorca P.M., Martinez J.L., Bougerol T., Scotto J.C. Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients. Encéphale 1997, 23(530):1-9.
18. Lincoln T.M., Lüllmann E., Rief W. Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. Schizophr. Bull. 2007, 33(6):1324-1342.
19. Lysaker P.H., Clements C.A., Plascak-Hallberq C.D., Knipscheer S.J., Wright D.E. Insight and personal narratives of illness in schizophrenia. Psychiatry 2002, 65(3):197-206.
20. Lysaker P.H., Bryson G.J., Lancaster R.S., et al. Insight in schizophrenia: association with executive function and coping style. Schizophr. Res. 2003, 59(1):41-47.
21. Lysaker P.H., Dimaggio G., Carcione A., et al. Metacognition and schizophrenia: the capacity for self-reflectivity as a predictor for positive assessments of work performance over six months. Schizophr. Res. 2010, 112:124-130.
22. Metcalfe J., Van Snellenberg J.X., DeRosse P., Balsam P., Malhotra A.K. Judgements of agency in schizophrenia: an impairment in autonoetic metacognition. Phil. Trans. R. Soc. B 2012, 367:1391-1400.
23. Mintz A.R., Dobson K.S., Romney D.M. Insight in schizophrenia: a meta-analysis. Schizophr. Res. 2003, 61:75-88.
24. Moore O., Cassidy E., Carr A., Callaghan E.O. Unawareness of illness and its relationship with depression and self-deception in schizophrenia. Eur. J. Psychiatr. 1999, 14:264-269.
25. Moritz S., Woodward T.S. Metacognitive training in schizophrenia: from basic research to knowledge translation and intervention. Curr. Opin. Psychiatr. 2007, 20:619-625.
26. Moritz S., Woodward T.S. Metacognitive training for schizophrenia patients (MCT): a pilot study on feasibility, treatment adherence, and subjective efficacy. Ger. J. Psychiatr. 2007, 10:69-78.
27. Moritz S., Woodward T.S., Burlon M. Metacognitive Skill Training for Patients with Schizophrenia (MCT), Manual 2005, VanHam Campus Verlag, Hamburg.
28. Moritz S., Vitzthum F., Randjbar S., Veckenstedt R., Woodward T.S. Detecting and defusing cognitive traps: metacognitive intervention in schizophrenia. Curr. Opin. Psychiatr. 2010, 23(6):561-569.
29. Moritz S., Veckenstedt R., Randjbar S., Vitzthum F., Woodward T.S. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms. Psychol. Med. 2011, 41(9):1823-1832.
30. Moritz S., Kerstan A., Veckenstedt R., Randjbar S., Vitzthum F., Schmidt C., Heise M., Woodward T.S. Further evidence for the efficacy of a metacognitive group training in schizophrenia. Behav. Res. Ther. 2011, 49:151-157.
31. Moritz S., Veckenstedt R., Bohn F., Hottenrott B., Scheu F., Randjbar S., Aghotor J., Köther U., Woodward T.S., Treszel A., Andreou C., Pfueller U., Roesch-Ely D. Complementary group Metacognitive Training (MCT) reduces delusional ideation in schizophrenia. Schizophr. Res. 2013, 151:61-69.
32. Pijnenborg G.H., Van der Gaag M., Bockting C.L., et al. REFLEX, a social-cognitive group treatment to improve insight in schizophrenia: study protocol of a multi-center RCT. BMC Psychiatr. 2011, 11:161.
33. Pijnenborg G.H.M., Van Donkersgoed R.J.M., David A.S., et al. Changes in insight during treatment for psychotic disorders: a meta-analysis. Schizophr. Res. 2013, 144:109-117. (Review).
34. Pini S., de Queiroz V., Dell'Osso L., et al. Cross-sectional similarities and differences between schizophrenia, schizoaffective disorder and mania or mixed mania with mood-incongruent psychotic features. Eur. Psychiatr. 2004, 19:8-14.
35. Raffard S., Bayard S., Gely-Nargeot M.C., et al. Insight and executive functioning in schizophrenia: a multidimensional approach. Psychiatry Res. 2009, 167:239-250.
36. Raffard S., Trouillet R., Capdevielle D., Gely-Nargeot M.C., Bayard S., Laroi F., et al. French adaptation and validation of the scale to assess unawareness of mental disorder. Can. J. Psychiatry 2010, 55:523-531.
37. Reine G., Bernard D., Auquier P., Le Fur B., Lançon C. Psychometric properties of French version of the Calgary depression scale for schizophrenics (CDSS). Encéphale 2000, 26(1):52-61.
38. Ross K., Freeman D., Dunn G., Garety P. A randomized experimental investigation of reasoning training for people with delusions. Schizophr. Bull. 2011, 37(2):324-333.
39. Smith T.E., Hull J.W., Huppert J.D., et al. Insight and recovery from psychosis in chronic schizophrenia and schizoaffective disorder patients. Psychiatry Res. 2004, 38:169-176.
40. Startup M. Insight and cognitive deficits in schizophrenia: evidence for a curvilinear relationship. Psychol. Med. 1996, 26:1277-1281.
41. Stone J.M., Pilowsky L.S. Antipsychotic drug action: targets for drug discovery with neurochemical imaging. Expert. Rev. Neurother. 2006, 6(1):57-64. (Review).
42. WHO Psychosocial Rehabilitation. A Consensus Statement 1996, World Health Organization, Geneva.
43. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J. Clin. Psychiatry 2003, 64:663-667.
44. Zink M., Englisch S., Meyer-Linderberg A. Polypharmacy in schizophrenia. Curr. Opin. Psychiatr. 2010, 23(2):103-111.